Ya-fei Yang
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis.
Journal: Expert review of gastroenterology & hepatology
Published: May 06, 2023
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis.
Journal: Immunotherapy
Published: May 04, 2023
Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity.
Journal: Cell death & disease
Published: January 24, 2023
The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis.
Journal: Expert review of gastroenterology & hepatology
Published: January 10, 2023
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.
Journal: Cancer letters
Published: January 05, 2023
A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response.
Journal: Frontiers in pharmacology
Published: November 18, 2022
The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma.
Journal: Heliyon
Published: August 25, 2022
Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: February 28, 2022
Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies.
Journal: Journal of Cancer
Published: August 01, 2021
CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity.
Journal: Molecular cancer
Published: December 09, 2020
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival.
Journal: Journal of Cancer
Published: November 19, 2020
Last Updated: 09/26/2026